SZSE:002864 (China)
Â
Class A
Â¥
30.59
(+2.17%)
May 14
Business Description
Shaanxi Panlong Pharmaceutical Group Ltd
ISIN : CNE1000032C9
Share Class Description:
SZSE:002864: Class ACompare
Compare
Traded in other countries / regions
002864.China IPO Date
2017-11-16Description
Shaanxi Panlong Pharmaceutical Group Ltd operates as a pharmaceuticals company. It manufactures and markets drugs for the treatment of traumatology, cardiovascular and cerebrovascular, respiratory, pediatrics, and hepatobiliary.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.66 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 1.06 | |||||
| Interest Coverage | 27.04 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.9 | |||||
| Beneish M-Score | -2.81 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.8 | |||||
| 3-Year EBITDA Growth Rate | 9.4 | |||||
| 3-Year EPS without NRI Growth Rate | 11.7 | |||||
| 3-Year FCF Growth Rate | 20.2 | |||||
| 3-Year Book Growth Rate | 20.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.01 | |||||
| 9-Day RSI | 63.21 | |||||
| 14-Day RSI | 57.48 | |||||
| 6-1 Month Momentum % | -34.76 | |||||
| 12-1 Month Momentum % | -38.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.16 | |||||
| Quick Ratio | 3.97 | |||||
| Cash Ratio | 2.85 | |||||
| Days Inventory | 80.47 | |||||
| Days Sales Outstanding | 156.53 | |||||
| Days Payable | 95.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.65 | |||||
| Dividend Payout Ratio | 0.16 | |||||
| 3-Year Dividend Growth Rate | 10.1 | |||||
| Forward Dividend Yield % | 0.65 | |||||
| 5-Year Yield-on-Cost % | 1.41 | |||||
| 3-Year Average Share Buyback Ratio | -7 | |||||
| Shareholder Yield % | 7.25 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.79 | |||||
| Operating Margin % | 13.26 | |||||
| Net Margin % | 12.43 | |||||
| FCF Margin % | 9.94 | |||||
| ROE % | 8.53 | |||||
| ROA % | 5.85 | |||||
| ROIC % | 17.64 | |||||
| ROC (Joel Greenblatt) % | 32.04 | |||||
| ROCE % | 9.53 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.71 | |||||
| PE Ratio without NRI | 24.75 | |||||
| Shiller PE Ratio | 34.37 | |||||
| Price-to-Owner-Earnings | 46.07 | |||||
| PEG Ratio | 1.95 | |||||
| PS Ratio | 3.19 | |||||
| PB Ratio | 2.06 | |||||
| Price-to-Tangible-Book | 2.13 | |||||
| Price-to-Free-Cash-Flow | 32.03 | |||||
| Price-to-Operating-Cash-Flow | 18.52 | |||||
| EV-to-EBIT | 14.94 | |||||
| EV-to-EBITDA | 14.94 | |||||
| EV-to-Revenue | 2.24 | |||||
| EV-to-FCF | 22.6 | |||||
| Price-to-Projected-FCF | 1.67 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.67 | |||||
| Price-to-Graham-Number | 1.53 | |||||
| Price-to-Net-Current-Asset-Value | 2.98 | |||||
| Price-to-Net-Cash | 5.82 | |||||
| Earnings Yield (Greenblatt) % | 6.69 | |||||
| FCF Yield % | 2.95 | |||||
| Forward Rate of Return (Yacktman) % | 10.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shaanxi Panlong Pharmaceutical Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 965.318 | ||
| EPS (TTM) (Â¥) | 1.19 | ||
| Beta | -0.06 | ||
| Volatility % | 39.73 | ||
| 14-Day RSI | 57.48 | ||
| 14-Day ATR (Â¥) | 0.937158 | ||
| 20-Day SMA (Â¥) | 28.219 | ||
| 12-1 Month Momentum % | -38.39 | ||
| 52-Week Range (Â¥) | 22 - 51.57 | ||
| Shares Outstanding (Mil) | 106.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shaanxi Panlong Pharmaceutical Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shaanxi Panlong Pharmaceutical Group Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shaanxi Panlong Pharmaceutical Group Ltd Frequently Asked Questions
What is Shaanxi Panlong Pharmaceutical Group Ltd(SZSE:002864)'s stock price today?
The current price of SZSE:002864 is ¥30.59. The 52 week high of SZSE:002864 is ¥51.57 and 52 week low is ¥22.00.
When is next earnings date of Shaanxi Panlong Pharmaceutical Group Ltd(SZSE:002864)?
The next earnings date of Shaanxi Panlong Pharmaceutical Group Ltd(SZSE:002864) is .
Does Shaanxi Panlong Pharmaceutical Group Ltd(SZSE:002864) pay dividends? If so, how much?
The Dividend Yield %  of Shaanxi Panlong Pharmaceutical Group Ltd(SZSE:002864) is 0.65% (As of Today), Highest Dividend Payout Ratio of Shaanxi Panlong Pharmaceutical Group Ltd(SZSE:002864) was 0.19. The lowest was 0.13. And the median was 0.16. The  Forward Dividend Yield % of Shaanxi Panlong Pharmaceutical Group Ltd(SZSE:002864) is 0.65%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers